BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29772997)

  • 1. Noncoding RNAs (ncRNA) in Hepato Cancer: A Review.
    Sun X; Malhotra A
    J Environ Pathol Toxicol Oncol; 2018; 37(1):15-25. PubMed ID: 29772997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
    Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K
    Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
    Eguchi H; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
    Xu K; Xia P; Chen X; Ma W; Yuan Y
    Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.
    Law PT; Qin H; Ching AK; Lai KP; Co NN; He M; Lung RW; Chan AW; Chan TF; Wong N
    J Hepatol; 2013 Jun; 58(6):1165-73. PubMed ID: 23376363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNAs in liver cancer: what we know in 2014.
    Zhao J; Greene CM; Gray SG; Lawless MW
    Expert Opin Ther Targets; 2014 Oct; 18(10):1207-18. PubMed ID: 25145388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma.
    Yang X; Xie X; Xiao YF; Xie R; Hu CJ; Tang B; Li BS; Yang SM
    Cancer Lett; 2015 May; 360(2):119-24. PubMed ID: 25721084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma.
    Pea A; Jamieson NB; Braconi C
    Hepatology; 2021 Jan; 73 Suppl 1():38-48. PubMed ID: 32160335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
    Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
    Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of non-coding RNAs mediates cisplatin resistance in hepatocellular carcinoma and therapeutic strategies.
    Xu XF; Yang XK; Song Y; Chen BJ; Yu X; Xu T; Chen ZL
    Pharmacol Res; 2022 Feb; 176():105906. PubMed ID: 34543740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
    Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
    Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
    Front Immunol; 2022; 13():847728. PubMed ID: 35281015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-coding RNAs as therapeutic targets in hepatocellular cancer.
    Braconi C; Patel T
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1073-80. PubMed ID: 22873215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.